首页> 外文期刊>The pharmaceutical journal >Background to ruling that AstraZeneca insert broke ABPI's Code of Practice
【24h】

Background to ruling that AstraZeneca insert broke ABPI's Code of Practice

机译:裁定阿斯利康插页违反ABPI的《行为准则》的背景

获取原文
获取原文并翻译 | 示例
           

摘要

In January and February this year,readers of The Pharmaceutical Journal reacted angrily to an educational insert distributed within the same wrapper as The Journal.Entitled 'The new NICE guidance on the use of statins in practice - Considerations for implementation',the insert (cover picture,right) was included with the 20 January issue.The NICE guidance referred to in the insert had been published the same month ("Statins for the prevention of cardiovascular events";Health Technology Appraisal 94).
机译:今年1月和2月,《 The Pharmaceutical Journal》的读者对与《 The Journal》在同一包装中分发的一个教育性插入内容做出了愤怒的反应。图片,右)已包含在1月20日的版本中。该插页中提到的NICE指南已于同月发布(“预防心血管事件的他汀类药物”;卫生技术评估94)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号